Skip to main content
. 2023 Jun 20;13(12):2128. doi: 10.3390/diagnostics13122128

Figure 2.

Figure 2

Scattergram showing the association between edoxaban-calibrated anti-Xa activity and the measurements of LC-MS/MS by drug. The overall correlation (rs) was 0.94 (95% CI 0.93, 0.95). It was 0.95 for rivaroxaban (95% CI 0.94, 0.96), 0.93 for apixaban (95% CI 0.91, 0.95), and 0.93 for edoxaban (95% CI 0.86, 0.97).